164 related articles for article (PubMed ID: 23111855)
1. Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia.
Palmsten K; Hernández-Díaz S; Kuriya B; Solomon DH; Setoguchi S
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1730-8. PubMed ID: 23111855
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine in Lupus Pregnancy and Risk of Preeclampsia.
Rector A; Marić I; Chaichian Y; Chakravarty E; Cantu M; Weisman MH; Shaw GM; Druzin ML; Simard JF
Arthritis Rheumatol; 2024 Jun; 76(6):919-927. PubMed ID: 38272838
[TBL] [Abstract][Full Text] [Related]
3. Early-onset Preeclampsia in Lupus Pregnancy.
Simard JF; Arkema EV; Nguyen C; Svenungsson E; Wikström AK; Palmsten K; Salmon JE
Paediatr Perinat Epidemiol; 2017 Jan; 31(1):29-36. PubMed ID: 27943386
[TBL] [Abstract][Full Text] [Related]
4. Medication use among pregnant women with systemic lupus erythematosus and general population comparators.
Palmsten K; Simard JF; Chambers CD; Arkema EV
Rheumatology (Oxford); 2017 Apr; 56(4):561-569. PubMed ID: 28013193
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.
Seo MR; Chae J; Kim YM; Cha HS; Choi SJ; Oh S; Roh CR
Lupus; 2019 May; 28(6):722-730. PubMed ID: 30971164
[TBL] [Abstract][Full Text] [Related]
6. Patterns of drug use in rheumatoid arthritis.
Bérard A; Solomon DH; Avorn J
J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
[TBL] [Abstract][Full Text] [Related]
7. Use of antimalarial drugs is associated with a lower risk of preeclampsia in lupus pregnancy: A prospective cohort study.
Saavedra MÁ; Miranda-Hernández D; Lara-Mejía A; Sánchez A; Morales S; Cruz-Reyes C; Cruz-Domínguez P; Medina G; Jara LJ
Int J Rheum Dis; 2020 May; 23(5):633-640. PubMed ID: 32227576
[TBL] [Abstract][Full Text] [Related]
8. Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies?
Do SC; Rizk NM; Druzin ML; Simard JF
Am J Perinatol; 2020 Jul; 37(9):873-880. PubMed ID: 31899930
[TBL] [Abstract][Full Text] [Related]
9. Patterns of medication use before, during and after pregnancy in women with systemic lupus erythematosus: a population-based cohort study.
Zusman EZ; Sayre EC; Aviña-Zubieta JA; De Vera MA
Lupus; 2019 Sep; 28(10):1205-1213. PubMed ID: 31311418
[TBL] [Abstract][Full Text] [Related]
10. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis.
Kawai VK; Grijalva CG; Arbogast PG; Curtis JR; Solomon DH; Delzell E; Chen L; Ouellet-Hellstrom R; Herrinton L; Liu L; Mitchel EF; Stein CM; Griffin MR
Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1415-24. PubMed ID: 22121511
[TBL] [Abstract][Full Text] [Related]
11. Patterns of medication use during pregnancy in rheumatoid arthritis.
Kuriya B; Hernández-Díaz S; Liu J; Bermas BL; Daniel G; Solomon DH
Arthritis Care Res (Hoboken); 2011 May; 63(5):721-8. PubMed ID: 21557526
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
Pastore DEA; Costa ML; Surita FG
Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations.
Accortt NA; Chung JB; Bonafede M; Limone BL; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2017; 12():2085-2094. PubMed ID: 28790811
[TBL] [Abstract][Full Text] [Related]
14. Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study.
Kolstad KD; Mayo JA; Chung L; Chaichian Y; Kelly VM; Druzin M; Stevenson DK; Shaw GM; Simard JF
BJOG; 2020 Jan; 127(1):70-78. PubMed ID: 31571337
[TBL] [Abstract][Full Text] [Related]
15. Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome.
Spinillo A; Beneventi F; Locatelli E; Ramoni V; Caporali R; Alpini C; Albonico G; Cavagnoli C; Montecucco C
Arthritis Rheumatol; 2016 Oct; 68(10):2555-62. PubMed ID: 27158919
[TBL] [Abstract][Full Text] [Related]
16. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis.
Liu Y; Zhang Y; Wei Y; Yang H
Arch Gynecol Obstet; 2021 Feb; 303(2):435-441. PubMed ID: 32880707
[TBL] [Abstract][Full Text] [Related]
18. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
Ward MM; Fries JF
J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
Bays AM; Gardner G
Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
[TBL] [Abstract][Full Text] [Related]
20. Determinants of first-line biological treatment in patients with rheumatoid arthritis: Results from an observational study.
Angelici L; Addis A; Agabiti N; Kirchmayer U; Davoli M; Belleudi V
Medicine (Baltimore); 2021 May; 100(19):e25943. PubMed ID: 34106665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
